Thai Foreign Minister Laments Placement On U.S. ‘Priority Watch List”
This article was originally published in PharmAsia News
Thailand's foreign minister said he was disappointed the United States decided to keep the country on its "priority watch list" of nations considered to have intellectual property rights protection issues. The minister did not mention the concerns of the United States regarding Thailand's compulsory licensing law targeting some foreign-made pharmaceuticals. Instead, he focused on the cooperation Thailand has given the United States in the area of stiffening actions against intellectual property piracy. The Office of U.S. Trade Representative said it remained concerned about the outcome of Thailand's compulsory licensing policy related to some foreign-made drugs. A USTR report said the agency is waiting to see if the new government retains the CL policy of the previous regime. (Click here for more
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.